Latest "Serono" News Stories

23:15 EST 18th December 2018 | BioPortfolio

Here are the most relevant search results for "Serono" found in our extensive news archives from over 250 global news sources.

More Information about Serono on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Serono for you to read. Along with our medical data and news we also list Serono Clinical Trials, which are updated daily. BioPortfolio also has a large database of Serono Companies for you to search.

Showing "Serono" News Articles 1–25 of 50

Extremely Relevant

Merck Serono: Launching a New Corporate Venture Fund

In this episode of PharmaTelevision News Review, Paul Larsmon talks with Roel Bulthuis, Head at Merck Serono Ventures. Filmed at BIO-Europe 2009, they discuss: • Merck Serono's new corporate venture fund • the motives behind the new venture fund • how investees can still develop other partnerships • a typical deal for Merck Serono under the new fund model • how early Merck Serono invests...


EMD Serono Taps Rehan Verjee as New President

EMD Serono is shaking up its leadership. The biopharmaceutical arm of Germany-based Merck KGaA named Rehan Verjee as the new president of EMD Serono and global head of innovative medicine franchises at the parent company.

Roel Bulthuis of Merck Serono Ventures- looking for new investment opportunities in oncology, neurodegeneration, inflammation, fertility and endocrinology

In this episode of PharmaTelevision News Review, Fintan Walton talks to Roel Bulthuis, Head of Merck Serono Ventures of Merck Serono SA

Merck Serono Secures Future Pipeline

In March 2009 Merck Serono announced that they had set up a strategic Venture Fund to invest in biotech companies with interesting programmes that are in line with Merck Serono’s strategic thinking. At BIO 2009 Dr. Jöern-Peter Halle, VP Early Stage Licensing, joined Fintan Walton to discuss how this fund will give the company enviable access to exciting innovation in their main therapy areas.

Phillippe Lopes-Fernandes talks about Merck Serono’s strengths and successes in partnering

In this episode of PharmaTelevision News Review, Fintan Walton talks to Phillippe Lopes-Fernandes, Corporate VP, Head of Global Business Development at Merck Serono

EMD Serono: Philippe M Lopes-Fernandes. Closure of Geneva site creates opportunities for new business successes

In this episode of PharmaTelevision News Review, filmed at BioEurope Spring 2013, in Barcelona, Spain, Fintan Walton talks to Philippe M Lopes-Fernandes, Senior VP, Head of Global Licensing, Business Development and Alliance Management at EMD Serono.

Accelerated Cure Project Collaborates with EMD Serono to Advance Patient-Focused Drug Development in Multiple Sclerosis

WALTHAM, Mass., Oct. 2, 2018 /PRNewswire/ — Accelerated Cure Project (ACP) for Multiple Sclerosis (MS) today announced it has entered into a ground-breaking collaboration with EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, to capture and integrate the perspectives of people affected by MS into the design and …

Rehan Verjee to Lead EMD Serono

Mr. Verjee will take accountability for the U.S. and Canada biopharmaceutical business

Vaccine Problems, PTV News: Mar 24, 2010

Merck Serono suspends trials of Stimuvax cancer vaccine after encephalitis case

Study examines effects of walking exercise training on cognitive function in people with MS

John DeLuca, PhD, senior vice president for Research and Training at Kessler Foundation, has received a $95,000 sub-award from EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada.

PTV News: Sep 14, 2009

Top stories on September 14th, 2009: Price-cutting: why J&J wants to pay less for Elan The year's biggest IPO: Talecris plans to raise more than US$800m The good and the bad for Merck Serono Medgenics groundbreaking biopump technology And snorting stem cells: how the nose could be the door to the brain

Novartis: Neuer Deal mit dem Bertarelli-Clan - Blick auf die Aktie!

Seit der Übernahme von Serono durch Merck mischt die Familie Bertarelli zwar noch im Biotech-Geschäft mit, aber nicht in der Größenordnung wie früher. Doch nun könnte die Familie und deren Firmenim...

FDA Accepts File for Cladribine Tablets as Potential Treatment for Relapsing Forms of Multiple Sclerosis

ROCKLAND, Mass., July 30, 2018 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced that a resubmission of the New Drug Application (NDA) for cladribine tablets as a...

PTV News: Nov 24, 2009

Top stories on November 24th, 2009: Cephalon's Cinquil set-back Biogen CEO attacked over share sales and pay Merck Serono plans global R&D centre in China Norway's Clavis in US$ 380M development deal Action Shares Teva "jumps gun" with Novartis generic "Take your tablets!" -  

PTV News: Jan 5, 2010

Top stories on January 5th, 2010: Targeting cancer: RNAi minnow in billion plus pact Wrinkle power: Merz’s move into aesthetic medicine Genzyme's "fill and finish" deal with Hospira Action Shares Venturing forth: Merck Serono's 40M Euro investment fund The C factor: How a humble vitamin fights accelerated ageing

News Headlines, PTV News: Mar 24, 2010

A look at today's forthcoming news stories: Pfizer and GSK in cut price vaccine deal for world's poorest; Merck Serono suspends trials of cancer vaccine after patient develops encephalitis, and Dynavax hepatitis vaccine equals GSK's rival in safety trials

Bavencio Review Timeline And Reviewers

Overview of development timeline and review team for EMD Serono’s Bavencio (avelumab) for metastatic Merkel cell carcinoma.   

PTV News: Nov 10, 2009

Top stories on November 10th, 2009: R&D rationalisation: Pfizer closes sites and slashes jobs Enzon sells off speciality pharma business Indian generics circle Lipitor Action shares Ranbaxy's issues with FDA will take "a long time" to resolve Merck Serono Ventures seeks early stage biotechs for investment

Probably Relevant

Executives On The Move: New Hires At EUSA Pharma And Asceneuron, Promotions At Merck And Casma Therapeutics

Bristol Myers-Squibb’s head of discovery joins Foghorn as chief scientific officer, EMD Serono’s head of neurology and immunology joins Cipher...   

Executives On The Move: Celgene Picks a Clinical Development Head And Axcella Health Gains a New CBO From Novartis

At NuVasive, a new CEO is slated to take charge. Celgene chooses as President, Global Clinical Development an exec from EMD Serono and Axcella Health fills its...   

ZymoGenetics: 25 Years Young: An Interview with Bruce Carter, President and CEO

Fintan Walton, CEO of PharmaVentures, talks exclusively to Bruce Carter, President and CEO of ZymoGenetics, a company that celebrated its 25th anniversary on 22 June 2006. Bruce discusses a number of aspects of ZymoGenetics' operations, including its relationship with previous owners Novo Nordisk, its alliance with Serono and its drug development model. Bruce also shares his views and advice on bi...

Former Armo Bio Exec Leveque Joins Synthorx as Chief Medical Officer

Synthorx has appointed Joseph Leveque to serve as chief medical officer of the San Diego biotech. Leveque most recently worked at Redwood City, CA-based cancer drug developer Armo Biosciences, which was acquired by Eli Lilly (NYSE: LLY) for $1.6 billion earlier this year. Leveque’s experience also includes senior roles at EMD Serono, Bristol-Myers Squibb (NYSE: […]

#jobs #lifescience Director – Bavencio Marketing, US

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Director – Bavencio Marketing, US .MA-Rockland, A career with EMD Serono is an ongoing journey of discovery: our 52,000 people are shaping how the world lives, works and … Continue reading → Cet article #jobs #lifescience Director – Bavencio Marketing, ...

#jobs #lifescience Program Lead, Oncology

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Program Lead, Oncology .MA-Billerica, A career with EMD Serono is an ongoing journey of discovery: our 50,000 people are shaping how the world lives, works and plays through … Continue reading → Cet article #jobs #lifescience Program Lead, Oncology est apparu en pr...

Theratechnologies nets $55.2mm in bought deal financing

Infectious disease-focused Theratechnologies Inc. netted $55.2mm (including full exercise of the overallotment) in a bought d...

Quick Search


News Quicklinks